Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee E Schechter

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
European Journal of Pharmacology|August 5, 2008
Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmissionBrian A Hoshaw, Tiffany I Hill, James J Crowley, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT(1A) antagonist component into a class of serotonin reuptake inhibitorsRichard E Mewshaw, Kristin L Meagher, Ping Zhou, et al.
Bioorganic & Medicinal Chemistry|July 13, 2007
Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonistsHassan Elokdah, David Li, Geraldine McFarlane, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
4-(2-Aminoethoxy)-N-(phenylsulfonyl)indoles as novel 5-HT6 receptor ligandsPing Zhou, Yinfa Yan, Ronald Bernotas, et al.
Journal of Medicinal Chemistry|July 9, 2004
Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylaminesRichard E Mewshaw, Dahui Zhou, Ping Zhou, et al.
The International Journal of Neuropsychopharmacology|May 14, 2009
5-HT(1A) receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in ratsStacey J Sukoff Rizzo, Claudine Pulicicchio, Jessica E Malberg, et al.
Neuropharmacology|April 22, 2008
WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agentZoë A Hughes, Feng Liu, Brian J Platt, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonistsDerek C Cole, John W Ellingboe, William J Lennox, et al.
Psychopharmacology|January 19, 2006
Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implicationsRobert H Ring, Jessica E Malberg, Lisa Potestio, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2005
Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonistsDerek C Cole, William J Lennox, Joseph R Stock, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|August 5, 2008
Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmissionBrian A Hoshaw, Tiffany I Hill, James J Crowley, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT(1A) antagonist component into a class of serotonin reuptake inhibitorsRichard E Mewshaw, Kristin L Meagher, Ping Zhou, et al.
Bioorganic & Medicinal Chemistry|July 13, 2007
Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonistsHassan Elokdah, David Li, Geraldine McFarlane, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
4-(2-Aminoethoxy)-N-(phenylsulfonyl)indoles as novel 5-HT6 receptor ligandsPing Zhou, Yinfa Yan, Ronald Bernotas, et al.
Journal of Medicinal Chemistry|July 9, 2004
Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylaminesRichard E Mewshaw, Dahui Zhou, Ping Zhou, et al.
The International Journal of Neuropsychopharmacology|May 14, 2009
5-HT(1A) receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in ratsStacey J Sukoff Rizzo, Claudine Pulicicchio, Jessica E Malberg, et al.
Neuropharmacology|April 22, 2008
WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agentZoë A Hughes, Feng Liu, Brian J Platt, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonistsDerek C Cole, John W Ellingboe, William J Lennox, et al.
Psychopharmacology|January 19, 2006
Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implicationsRobert H Ring, Jessica E Malberg, Lisa Potestio, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2005
Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonistsDerek C Cole, William J Lennox, Joseph R Stock, et al.
Pageof 7